Explore the latest developments in the US biosimilar market, highlighting key approvals, challenges, and future trends ...

After consistently delivering on commitments in first two years as standalone company, Sandoz has unique leading position in biosimilar and generic market Strong momentum supports plans to capture ...

It’s been more than ten years since the FDA signed off on the United States’ first biosimilar product, opening up what was ...

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Biosimilar Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Industry groups are urging changes to the US Food and Drug Administration’s Biosimilar User Fee Amendments programme as talks ...

There are critical gaps in biosimilar adoption for pediatric patients, focusing on safety, regulatory challenges, and the ...

Alvotech, a biotech firm focused on biosimilar medicine development, announced the acquisition of Xbrane Biopharma’s R&D operations and a biosimilar candidate named XB003, aimed at extending its ...

The global biosimilar testing and development services industry is transforming due to factors such as a surge in R&D investments on biosimilar testing, patent expiration of original drugs, and rise ...

Planegg-Martinsried - Formycon AG (FSE: FYB, “Formycon”) announced today that the clinical development program for FYB206, a biosimilar for Keytruda ® / pembrolizumab, has started with the inclusion ...

The global population is growing and ageing, placing an ever-increasing financial strain on the world’s healthcare systems. 1 Biosimilar medicines offer an economically viable solution by making ...